Stock Track | PA GOODDOCTOR Soars 12.96% Intraday on Strong 2025 Earnings Beat and Citigroup Buy Rating

Stock Track
03/25

PA GOODDOCTOR's stock price surged 12.96% during intraday trading on Wednesday, following the release of its impressive 2025 financial results and a bullish analyst report.

The company reported a significant year-on-year increase in both revenue and net profit for 2025, with earnings substantially exceeding market expectations. This strong performance, coupled with improved profit margins driven by AI initiatives and efficiency management, provided a fundamental catalyst for the sharp price appreciation.

Adding to the positive sentiment, Citigroup issued a research report affirming a "Buy" rating on the stock and setting a target price of HK$18, citing the earnings beat and the company's strengthened financial profile.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10